Jasveet Brar became manager of the M&G Better Health Solutions strategy in June 2021 having been part of the M&G Positive Impact team since its establishment in 2018. He was also appointed Fund Manager of the Taishin Future Health Fund in October 2022. Jasveet joined the M&G Equity team in December 2012 as a dedicated investment analyst with the Sustain franchise, leading on environmental, social and governance (ESG) analysis and company engagement. He is a CFA charterholder and started his career with M&G as part of the graduate scheme in September 2011. Jasveet graduated from University College London with a first class honours BSc in Mathematics.
Impact investors aim to invest in companies providing innovative, impactful solutions to the world’s most pressing environmental and social challenges, such as the provision of good health and well-being. In this article, we take a closer look at genomics, an innovative technology with the potential to improve healthcare efficiency, reduce suffering and ultimately save lives.